semaglutide blood work Ozempic, Wegovy and Mounjaro (GLP-1) Test Blood Tests Before Semaglutide |

The main safety concern involves compounded GLP-1 medications, which lack FDA oversight for quality and consistency

No, increasing the dose too quickly can cause severe side effects like nausea and vomiting

It is also an injection

Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity

Based on AEs as reported in the European EudraVigilance database, gallbladder disease is likely not limited to liraglutide, but affects all incretin-based therapies (85)